HK Stock MarketDetailed Quotes

01177 SINO BIOPHARM

Watchlist
  • 2.340
  • -0.090-3.70%
Market Closed Apr 19 16:08 CST
43.99BMarket Cap17.08P/E (TTM)

SINO BIOPHARM Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(Q3)Mar 31, 2021
(FY)Dec 31, 2020
(Q9)Sep 30, 2020
(Q6)Jun 30, 2020
Turnover
0.67%26.2B
0.55%15.28B
-3.11%26.03B
5.85%15.19B
13.59%26.86B
13.49%14.35B
16.41%7.24B
-2.42%23.65B
-6.18%18.13B
0.96%12.65B
Operating income
0.67%26.2B
0.55%15.28B
-3.11%26.03B
5.85%15.19B
13.59%26.86B
13.49%14.35B
16.41%7.24B
-2.42%23.65B
-6.18%18.13B
0.96%12.65B
Cost of sales
-11.19%-4.99B
-10.03%-3.26B
15.84%-4.49B
-7.50%-2.96B
-2.89%-5.33B
1.39%-2.75B
-11.75%-1.42B
-5.20%-5.18B
-8.05%-4.07B
-13.86%-2.79B
Operating expenses
-11.19%-4.99B
-10.03%-3.26B
15.84%-4.49B
-7.50%-2.96B
-2.89%-5.33B
1.39%-2.75B
-11.75%-1.42B
-5.20%-5.18B
-8.05%-4.07B
-13.86%-2.79B
Gross profit
-1.53%21.21B
-1.75%12.02B
0.04%21.54B
5.46%12.23B
16.60%21.53B
17.70%11.6B
17.60%5.83B
-4.37%18.46B
-9.64%14.05B
-2.18%9.86B
Selling expenses
6.28%-9.19B
6.42%-5.38B
6.74%-9.81B
-1.52%-5.75B
-17.23%-10.52B
-22.83%-5.67B
-22.58%-3.05B
3.72%-8.97B
9.65%-6.86B
6.52%-4.61B
Administrative expenses
1.38%-1.87B
10.17%-1.06B
13.08%-1.9B
-4.97%-1.18B
17.72%-2.19B
-6.90%-1.13B
-1.69%-448.06M
-7.21%-2.66B
-4.58%-1.79B
-1.45%-1.05B
Operating interest expense
----
-79.67%-304.14M
----
-14.98%-169.27M
4.56%-308.62M
15.55%-147.22M
20.76%-71.66M
-40.63%-323.37M
----
---174.32M
Special items of operating profit
7.95%-3.71B
2.72%-1.83B
-12.79%-4.03B
-48.22%-1.88B
-138.87%-3.58B
7.01%-1.27B
-38.40%-889.49M
12.04%-1.5B
20.02%-1.3B
1.92%-1.36B
Operating profit
10.93%6.43B
5.91%3.44B
17.31%5.8B
-4.19%3.25B
-1.48%4.94B
27.98%3.39B
5.76%1.36B
-10.09%5.02B
-11.24%4.09B
-2.23%2.65B
Financing cost
-15.31%-495.24M
----
---429.49M
----
----
----
----
----
-99.15%-265.46M
----
Share of profits of associates
-243.66%-525.71M
-143.61%-219.44M
-101.12%-152.98M
-93.37%503.16M
421,714.29%13.63B
18,515.51%7.58B
59,124.43%1.48B
-102.90%-3.23M
-1,230.97%-86.72M
-637.00%-41.19M
Earning before tax
3.74%5.41B
-14.13%3.22B
-71.92%5.21B
-65.80%3.75B
270.49%18.57B
320.56%10.98B
119.74%2.84B
-11.91%5.01B
-16.60%3.74B
-0.87%2.61B
Tax
-14.43%-797.27M
8.16%-524.74M
64.41%-696.72M
57.26%-571.39M
-191.19%-1.96B
-144.71%-1.34B
-106.47%-446.94M
25.52%-672.38M
6.56%-777.69M
-21.50%-546.33M
After-tax profit from continuing operations
2.09%4.61B
-15.20%2.7B
-72.81%4.52B
-66.98%3.18B
282.77%16.61B
367.10%9.64B
122.41%2.39B
-9.34%4.34B
-18.89%2.96B
-5.48%2.06B
After-tax profit from non-continuing business
0.06%484.76M
----
--484.47M
----
----
----
----
----
----
----
Earning after tax
1.89%5.1B
-15.20%2.7B
-69.89%5B
-66.98%3.18B
282.77%16.61B
367.10%9.64B
122.41%2.39B
-9.34%4.34B
-18.89%2.96B
-5.48%2.06B
Minority profit
12.46%2.77B
14.14%1.44B
22.56%2.46B
8.69%1.26B
27.83%2.01B
41.01%1.16B
139.53%480.92M
-22.54%1.57B
-20.41%1.11B
11.37%823.52M
Profit attributable to shareholders
-8.32%2.33B
-34.47%1.26B
-82.59%2.54B
-77.35%1.92B
427.17%14.61B
583.56%8.48B
118.49%1.91B
0.35%2.77B
-17.96%1.85B
-14.11%1.24B
Basic earnings per share
-7.83%0.1259
-34.17%0.0678
-82.45%0.1366
-77.19%0.103
428.02%0.7783
584.09%0.4515
118.67%0.1019
0.41%0.1474
-17.91%0.0981
-42.46%0.066
Diluted earnings per share
3.62%0.1259
-26.30%0.0678
-83.42%0.1215
-78.79%0.092
397.01%0.7326
557.27%0.4338
151.49%0.0928
0.41%0.1474
-17.91%0.0981
-42.46%0.066
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
--
Ernst & Young
--
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(Q3)Mar 31, 2021(FY)Dec 31, 2020(Q9)Sep 30, 2020(Q6)Jun 30, 2020
Turnover 0.67%26.2B0.55%15.28B-3.11%26.03B5.85%15.19B13.59%26.86B13.49%14.35B16.41%7.24B-2.42%23.65B-6.18%18.13B0.96%12.65B
Operating income 0.67%26.2B0.55%15.28B-3.11%26.03B5.85%15.19B13.59%26.86B13.49%14.35B16.41%7.24B-2.42%23.65B-6.18%18.13B0.96%12.65B
Cost of sales -11.19%-4.99B-10.03%-3.26B15.84%-4.49B-7.50%-2.96B-2.89%-5.33B1.39%-2.75B-11.75%-1.42B-5.20%-5.18B-8.05%-4.07B-13.86%-2.79B
Operating expenses -11.19%-4.99B-10.03%-3.26B15.84%-4.49B-7.50%-2.96B-2.89%-5.33B1.39%-2.75B-11.75%-1.42B-5.20%-5.18B-8.05%-4.07B-13.86%-2.79B
Gross profit -1.53%21.21B-1.75%12.02B0.04%21.54B5.46%12.23B16.60%21.53B17.70%11.6B17.60%5.83B-4.37%18.46B-9.64%14.05B-2.18%9.86B
Selling expenses 6.28%-9.19B6.42%-5.38B6.74%-9.81B-1.52%-5.75B-17.23%-10.52B-22.83%-5.67B-22.58%-3.05B3.72%-8.97B9.65%-6.86B6.52%-4.61B
Administrative expenses 1.38%-1.87B10.17%-1.06B13.08%-1.9B-4.97%-1.18B17.72%-2.19B-6.90%-1.13B-1.69%-448.06M-7.21%-2.66B-4.58%-1.79B-1.45%-1.05B
Operating interest expense -----79.67%-304.14M-----14.98%-169.27M4.56%-308.62M15.55%-147.22M20.76%-71.66M-40.63%-323.37M-------174.32M
Special items of operating profit 7.95%-3.71B2.72%-1.83B-12.79%-4.03B-48.22%-1.88B-138.87%-3.58B7.01%-1.27B-38.40%-889.49M12.04%-1.5B20.02%-1.3B1.92%-1.36B
Operating profit 10.93%6.43B5.91%3.44B17.31%5.8B-4.19%3.25B-1.48%4.94B27.98%3.39B5.76%1.36B-10.09%5.02B-11.24%4.09B-2.23%2.65B
Financing cost -15.31%-495.24M-------429.49M---------------------99.15%-265.46M----
Share of profits of associates -243.66%-525.71M-143.61%-219.44M-101.12%-152.98M-93.37%503.16M421,714.29%13.63B18,515.51%7.58B59,124.43%1.48B-102.90%-3.23M-1,230.97%-86.72M-637.00%-41.19M
Earning before tax 3.74%5.41B-14.13%3.22B-71.92%5.21B-65.80%3.75B270.49%18.57B320.56%10.98B119.74%2.84B-11.91%5.01B-16.60%3.74B-0.87%2.61B
Tax -14.43%-797.27M8.16%-524.74M64.41%-696.72M57.26%-571.39M-191.19%-1.96B-144.71%-1.34B-106.47%-446.94M25.52%-672.38M6.56%-777.69M-21.50%-546.33M
After-tax profit from continuing operations 2.09%4.61B-15.20%2.7B-72.81%4.52B-66.98%3.18B282.77%16.61B367.10%9.64B122.41%2.39B-9.34%4.34B-18.89%2.96B-5.48%2.06B
After-tax profit from non-continuing business 0.06%484.76M------484.47M----------------------------
Earning after tax 1.89%5.1B-15.20%2.7B-69.89%5B-66.98%3.18B282.77%16.61B367.10%9.64B122.41%2.39B-9.34%4.34B-18.89%2.96B-5.48%2.06B
Minority profit 12.46%2.77B14.14%1.44B22.56%2.46B8.69%1.26B27.83%2.01B41.01%1.16B139.53%480.92M-22.54%1.57B-20.41%1.11B11.37%823.52M
Profit attributable to shareholders -8.32%2.33B-34.47%1.26B-82.59%2.54B-77.35%1.92B427.17%14.61B583.56%8.48B118.49%1.91B0.35%2.77B-17.96%1.85B-14.11%1.24B
Basic earnings per share -7.83%0.1259-34.17%0.0678-82.45%0.1366-77.19%0.103428.02%0.7783584.09%0.4515118.67%0.10190.41%0.1474-17.91%0.0981-42.46%0.066
Diluted earnings per share 3.62%0.1259-26.30%0.0678-83.42%0.1215-78.79%0.092397.01%0.7326557.27%0.4338151.49%0.09280.41%0.1474-17.91%0.0981-42.46%0.066
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion----Unqualified Opinion----
Auditor Ernst & Young--Ernst & Young--Ernst & Young----Ernst & Young----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg